| Active ingredient (INN) | Certolizumab Pegol |
|---|---|
| Brand names | Cimzia |
| ATC level 5 | L04AB05 |
| ATC level 4 | L04AB |
| Therapeutic category | Auto-created by EMA — Withdrawn / Refused / Revoked Medicines scraper |
| Controlled substance | No |
| Marketing-authorisation holders | UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia |
| Registrations on file | 1 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| CIMZIA certolizumab pegol | 200 mg | — | 🇦🇺 AU | UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia | Active |